At Biogenesis we aspire to deliver to patients and their caregivers the most innovative treatment solutions possible in order to live their lives to the fullest.
We are passionate and focused to offer groundbreaking biopharmaceutical products in therapeutic areas of high unmet medical need, thus fulfilling our mission to serve patients, their families as also their treating physicians in their fight against severe, chronic and rare diseases.
Our long-time expertise of the Greek pharmaceutical market across many therapeutic areas and our strong business acumen gained after year-long working experience in major multinational pharmaceutical companies guarantee the value maximization and returns of our business partners.
We are currently focused on achieving collaborations and distribution agreements with multinational companies, that would allow us to enrich our portfolio with Specialty and Rare Diseases products as also products from the therapeutic areas of Immunology, Haematology and Oncology. Our main interest lies in new and innovative therapeutic approaches with or without orphan drug status, where Phase III clinical trials have been completed and for which FDA and EMA marketing authorization procedures have started or are expected to start.
Our Mission is to serve patients, their families as also their treating physicians in their fight against severe, chronic and rare diseases. We strive to fulfill our mission by providing access to innovative therapeutic solutions. We aspire to be the partner of choice for multinational pharmaceutical companies seeking to enter the Greek healthcare market. We guarantee the most professional and highest level of service and commitment as also leadership positioning in the local market.
Our long-term vision is to be acknowledged as a biopharma company that provides innovative, high quality therapeutic solutions, that improve health and quality of life in our society, while creating maximum value for our customers, business partners and employees